Meredith McKean, M.D.

Meredith McKean, M.D., MPH, is a board-certified medical oncologist and the director of Melanoma and Skin Cancer Research for Sarah Cannon Research Institute. She specializes in skin cancer treatment and research in addition to phase 1 drug development. In her role at Sarah Cannon, Dr. McKean oversees investigational therapy trials for melanoma and other skin cancers. In 2017, she earned an ASCO Conquer Cancer Foundation Young Investigator Award, and in 2018, she received the MD Anderson Cancer